Podcasts
Blueprint for Building a Better Data Governance Framework
Data Governance is an extremely important component of a digital transformation and being able to manage the critical implementation of strategies, methods, and frameworks
for data governance is an imperative to ensure success overall in the transformation.
In this episode, we focus on the importance of Data Governance in the biopharma industry. We look at some key factors contributing to developing
a successful Data Governance program speaking with our experts on the topic.
Click here to access
Better Data for Better Decisions
With COVID (hopefully) in retreat, healthcare delivery organizations (HDOs) can renew their focus on the Quadruple Aim of healthcare. Every HDO has thousands of medical devices used by thousands
of nurses, and each costs thousands of dollars. By improving the utilization and management of these devices, HDOs can significantly lower the per capita cost of delivering care and enhance the quality of the work-life for their front-line
care teams.
Click here to access
SDBN BUZZ Podcast: Eric Topol: Will AI Improve or Erode the Doctor Patient Relationship?
In this episode, Dr Eric Topol, Executive Vice Rresident at Scripps Research and the founder and director of Scripps Research Translational Institute, describes what some of those advances might look like for both the doctor and the patient.
Click here to access
In this episode, Dr Eric Topol, Executive Vice Rresident at Scripps Research and the founder and director of Scripps Research Translational Institute, describes what some of those advances might look like for both the doctor and the patient.
Click here to access
SDBN BUZZ Podcast: Three Essentials to Advance Your Life Science Career – And Advice for Employers Too
Robin Toft is the Chairman and Founder of The Toft Group, an executive search firm and author of the book: We Can: The Executive Woman’s Guide to Career Advancement. In this episode she shares three things you must have to advance your career Confidence, Competence and Connections) and how to develop/deploy them. This episode is packed with good advice. Here are some highlights. You are the CEO of you. You should spend 75% of your time creating excellent value for your company. The other 25% should be spent planning how you can add more. Every CEO is thinking ahead and you should to. Companies value people who can think ahead strategically.
Click here to access
Robin Toft is the Chairman and Founder of The Toft Group, an executive search firm and author of the book: We Can: The Executive Woman’s Guide to Career Advancement. In this episode she shares three things you must have to advance your career Confidence, Competence and Connections) and how to develop/deploy them. This episode is packed with good advice. Here are some highlights. You are the CEO of you. You should spend 75% of your time creating excellent value for your company. The other 25% should be spent planning how you can add more. Every CEO is thinking ahead and you should to. Companies value people who can think ahead strategically.
Click here to access
Leading the Shift Towards Value-Based Care with Atrius Health CEO Dr. Steve Strongwater
With value-based care (VBC) at its core, Atrius Health focuses on prevention, population health management and creating full alignment with patients and patient care needs. In this episode of Healthcare Is Hard: A Podcast for Insiders, Keith Figlioli talks to Atrius Health CEO Dr. Steven Strongwater about the challenges of moving to risk-based reimbursement, the successes Atrius Health has seen thus far, and next steps in the organization’s journey.
Click here to access
With value-based care (VBC) at its core, Atrius Health focuses on prevention, population health management and creating full alignment with patients and patient care needs. In this episode of Healthcare Is Hard: A Podcast for Insiders, Keith Figlioli talks to Atrius Health CEO Dr. Steven Strongwater about the challenges of moving to risk-based reimbursement, the successes Atrius Health has seen thus far, and next steps in the organization’s journey.
Click here to access
Healthcare is Hard: Reinventing the Consumer Experience at AdventHealth podcast
In this episode of the Healthcare Is Hard: A Podcast for Insiders, Terry recounts the expansion and evolution of AdventHealth, including its growth from a $2 billion to a $12 billion system over the past 20 years. He also talks to Keith Figlioli about the initiatives underway at AdventHealth to revolutionize the future of patient care.
Click here to access
In this episode of the Healthcare Is Hard: A Podcast for Insiders, Terry recounts the expansion and evolution of AdventHealth, including its growth from a $2 billion to a $12 billion system over the past 20 years. He also talks to Keith Figlioli about the initiatives underway at AdventHealth to revolutionize the future of patient care.
Click here to access
Advancing Life Sciences Research: Accelerating innovation in the age of cloud
For decades, high-performance computing (HPC) has played a crucial role in advancing healthcare. Enabled by techniques like next-generation sequencing (NGS), modern computer systems have helped us understand the biology of disease and helped facilitate the development of newer more effective drugs. While once deployed mainly in research, today HPC is edging ever closer to front-line clinical care supporting advanced diagnostics, genetic counseling, and personalized medicine.
Click here to access
For decades, high-performance computing (HPC) has played a crucial role in advancing healthcare. Enabled by techniques like next-generation sequencing (NGS), modern computer systems have helped us understand the biology of disease and helped facilitate the development of newer more effective drugs. While once deployed mainly in research, today HPC is edging ever closer to front-line clinical care supporting advanced diagnostics, genetic counseling, and personalized medicine.
Click here to access
The Spotlight on IRT: Best Practices
Mid-study protocol changes. Regulatory audit demands. Challenging technology integrations…Sound familiar? Today’s clinical trials are certainly more complex and demanding, and ensuring safety while saving time and money is something everyone wants. Too often in clinical development, we get caught up in our own processes and forget that there’s other ways to approach a problem. We know the struggles you have in the Interactive Response Technology (IRT) world and we want to help! Here at Almac Clinical Technologies, we are in a unique position to share some of the best practices we’ve seen from our wide and diverse client base. Join Matt Lowrie, your host for each episode of the Spotlight on IRT podcast, where he will answer your questions, discuss common pain points, and talk to industry leaders to help you drive efficiencies and prevent unnecessary risks. Find us on iTunes, Google Play or wherever else you listen!
Click here to access
Mid-study protocol changes. Regulatory audit demands. Challenging technology integrations…Sound familiar? Today’s clinical trials are certainly more complex and demanding, and ensuring safety while saving time and money is something everyone wants. Too often in clinical development, we get caught up in our own processes and forget that there’s other ways to approach a problem. We know the struggles you have in the Interactive Response Technology (IRT) world and we want to help! Here at Almac Clinical Technologies, we are in a unique position to share some of the best practices we’ve seen from our wide and diverse client base. Join Matt Lowrie, your host for each episode of the Spotlight on IRT podcast, where he will answer your questions, discuss common pain points, and talk to industry leaders to help you drive efficiencies and prevent unnecessary risks. Find us on iTunes, Google Play or wherever else you listen!
Click here to access
Harnessing the power of Big Data and AI for faster, better, and more efficient studies
As more patients become connected, there’s a new data source that can help us understand and engage patients-- data collected passively through wearables, devices, apps and sensors. Envision being able to gather minute-level data directly from patients, monitor adherence to a protocol outside of brick and mortar walls, and enroll patients into a study within 24 hours -- all of these scenarios are possible in the digital era of medicine.
Click here to access
As more patients become connected, there’s a new data source that can help us understand and engage patients-- data collected passively through wearables, devices, apps and sensors. Envision being able to gather minute-level data directly from patients, monitor adherence to a protocol outside of brick and mortar walls, and enroll patients into a study within 24 hours -- all of these scenarios are possible in the digital era of medicine.
Click here to access
Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight
Real World Evidence (RWE) is today’s big data challenge in Life Sciences. Medical records, registries, consultation reports, insurance claims, pharmacy data, social media, and patient surveys all contain valuable insights that Life Sciences organizations need to ascertain and prove the safety, efficacy and value of their drugs and medical devices.
Click here to access
Real World Evidence (RWE) is today’s big data challenge in Life Sciences. Medical records, registries, consultation reports, insurance claims, pharmacy data, social media, and patient surveys all contain valuable insights that Life Sciences organizations need to ascertain and prove the safety, efficacy and value of their drugs and medical devices.
Click here to access
Strategic Challenges in the Bio IT Infrastructure Landscape
Genomics analyses have become much more affordable over the recent years. Creating a growth that makes the Life Science market projected to be worth 20 Billion US Dollars by 2020. In fact, research centers and hospitals specialized in the fields of Bio IT, Sequencing and other Life Sciences have acquired the latest technologies for their applications. As the demand for genomics analyses grows, these organizations are constantly creating new and more digital information. Therefore, IT managers are confronted with the impact of Big Data and must improve their IT infrastructure to respond to the needs of their workflows. Mr. Steven Rietveld, of NODEUM, will introduce this market and its related challenges during this podcast.
Click here to access
Genomics analyses have become much more affordable over the recent years. Creating a growth that makes the Life Science market projected to be worth 20 Billion US Dollars by 2020. In fact, research centers and hospitals specialized in the fields of Bio IT, Sequencing and other Life Sciences have acquired the latest technologies for their applications. As the demand for genomics analyses grows, these organizations are constantly creating new and more digital information. Therefore, IT managers are confronted with the impact of Big Data and must improve their IT infrastructure to respond to the needs of their workflows. Mr. Steven Rietveld, of NODEUM, will introduce this market and its related challenges during this podcast.
Click here to access
Genomic Medicine: Bioinformatics, Whole Genomes and the Future of the Field
Listen to a new speaker podcast with Dr. Liz Worthey of HudsonAlpha Institute for Biotechnology, as she discusses recent advances in informatics as they pertain to genomic medicine, the importance of focusing on whole genomes for clinical purposes rather than just exomes or gene panels, and how to move the field of genomic medicine ahead.
Click here to access
Listen to a new speaker podcast with Dr. Liz Worthey of HudsonAlpha Institute for Biotechnology, as she discusses recent advances in informatics as they pertain to genomic medicine, the importance of focusing on whole genomes for clinical purposes rather than just exomes or gene panels, and how to move the field of genomic medicine ahead.
Click here to access
Cost effective bioinformatics solutions for high volume bacterial strain typing & quantification
As demand for NGS grows in research organizations, so does the need to store, manage and analyze NGS data. Historically this has been accomplished with complex hardware and software infrastructures — which generate challenges for maintenance, cost and turn-around-time, and user-friendliness. Our goal is to give full control of NGS data back to our customers, enabling you to focus on science. This is why we created the High Volume Sequencing Solution, a software platform that provides full control over your data processing for any data volume. During this podcast, QIAGEN Bioinformatics and Mads Bennedsen from Christian Hansen discuss Building an Automated High Throughput Genome Sequence Analysis Pipeline using CLC Genomic Workbench and CLC Genomics Server.
Click here to access
As demand for NGS grows in research organizations, so does the need to store, manage and analyze NGS data. Historically this has been accomplished with complex hardware and software infrastructures — which generate challenges for maintenance, cost and turn-around-time, and user-friendliness. Our goal is to give full control of NGS data back to our customers, enabling you to focus on science. This is why we created the High Volume Sequencing Solution, a software platform that provides full control over your data processing for any data volume. During this podcast, QIAGEN Bioinformatics and Mads Bennedsen from Christian Hansen discuss Building an Automated High Throughput Genome Sequence Analysis Pipeline using CLC Genomic Workbench and CLC Genomics Server.
Click here to access
For more information contact
Patricia Rose, Sr. Business Development Manager, at prose@healthtech.com or 781-972-1349